Thalidomide, deep venous thrombosis and vasculitis [9]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 11, 2004, Pages 2062-2063

  Silingardi, Mauro ^a   Iotti, M ^a   Trenti, C ^a   Salvarani, C ^a   Iori, I ^a  

^a UO Pneumologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CORTICOSTEROID; DALTEPARIN; PHOSPHOLIPID ANTIBODY; THALIDOMIDE; VASCULOTROPIN; VON WILLEBRAND FACTOR; WARFARIN;

ACTIVATED PROTEIN C RESISTANCE; BEHCET DISEASE; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; LETTER; LIMB PAIN; LIMB SWELLING; LUNG EMBOLISM; MULTIPLE MYELOMA; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TERMINAL DISEASE; THROMBOPHILIA; THROMBOPHLEBITIS; VASCULITIS; VENOUS THROMBOEMBOLISM;

AGED; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; THALIDOMIDE; VASCULITIS; VENOUS THROMBOSIS;

EID: 13244262619     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00952.x     Document Type: Letter

References (7)

1. Rodeghiero F, Elice F. Thalidomide and thrombosis. Pathophysiol Haemost Thromb 2003; 33 (Suppl. 1): 15-8.
2. Ossandon A, Cassar EAM, Priori R, Valesini G. Thalidomide: focus on its employment in rheumatologic diseases. Clin Exp Rheumatol 2002; 20: 709-18.
3. Minnema MC, Fijnheer R, De Groot PG, Lokhorst HM. Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment. J Thromb Haemost 2003; 1: 445-9.
4. Barbui T, Falanga A. Thalidomide and thrombosis in multiple myeloma. J Thromb Haemost 2003; 1: 421-2.
5. Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Medical 1999; 341: 1284-91.
6. Salvarani C, Calamia K, Silingardi M, Ghirarduzzi A, Olivieri I. Thrombosis associated with the prothrombin G-A20210 mutation in Behcet's disease. J Rheumatol 2000; 27: 515-6.
7. Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet's syndrome: a randomised double-blind, placebo-controlled trial. Ann Intern Med 1998; 128 443-50.